InsiderClue
Stocks · Health care · Pharmaceutical Preparations

KIORA PHARMACEUTICALS INC

KPRX Clue Score54
United States Fiscal year ends December CIK 0001372514
$2.54 +0.40% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.54 +33.68% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.7Net income−13.3Fiscal year 2017Revenue0.4 −39.1%Net income−13.2Fiscal year 2018Revenue1.7 +305.5%Operating income−10.8Net income−10.8Fiscal year 2019Revenue2.7 +62.5%Net income−7.1Fiscal year 2020Revenue0.0 −99.6%Operating income−6.9Net income−6.9EPS, diluted−1.49Fiscal year 2021Revenue0.0 −100.0%Operating income−14.2Net income−13.8EPS, diluted−57.12Fiscal year 2022Operating income−12.3Net income−13.6EPS, diluted−18.55Fiscal year 2023Revenue0.0Operating income−12.6Net income−12.5EPS, diluted−24.25Fiscal year 2024Revenue16.0Operating income4.5Net income3.6EPS, diluted0.87Fiscal year 2025Revenue0.0 −100.0%Operating income−12.8Net income−10.8 −401.4%EPS, diluted−2.64
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.7 0.4 1.7 2.7 0.0 0.0 n/a 0.0 16.0 0.0
Growth −39.1% +305.5% +62.5% −99.6% −100.0% −100.0%
Operating income n/a n/a −10.8 n/a −6.9 −14.2 −12.3 −12.6 4.5 −12.8
Net income −13.3 −13.2 −10.8 −7.1 −6.9 −13.8 −13.6 −12.5 3.6 −10.8
Growth −401.4%
EPS, diluted n/a n/a n/a n/a −1.49 −57.12 −18.55 −24.25 0.87 −2.64

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Net margin−1,993.8%Free cash flow margin−1,257.1%Fiscal year 2017Net margin−3,243.5%Free cash flow margin−1,596.4%Fiscal year 2018Operating margin−656.3%Net margin−654.2%Free cash flow margin−657.5%Fiscal year 2019Net margin−264.2%Free cash flow margin−303.6%Fiscal year 2020Operating margin−56,960.5%Net margin−56,901.7%Free cash flow margin−60,844.6%Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Operating margin28.2%Net margin22.4%Free cash flow margin53.4%Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a −656.3% n/a −56,960.5% n/a n/a n/a 28.2% n/a
Net margin −1,993.8% −3,243.5% −654.2% −264.2% −56,901.7% n/a n/a n/a 22.4% n/a
Free cash flow margin −1,257.1% −1,596.4% −657.5% −303.6% −60,844.6% n/a n/a n/a 53.4% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−8.4Capital expenditure0.0Free cash flow−8.4Fiscal year 2017Operating cash flow−6.5Capital expenditure−0.0Free cash flow−6.5Fiscal year 2018Operating cash flow−10.8Capital expenditure−0.0Free cash flow−10.9Fiscal year 2019Operating cash flow−8.2Capital expenditure0.0Free cash flow−8.2Fiscal year 2020Operating cash flow−7.3Capital expenditure−0.0Free cash flow−7.3Fiscal year 2021Operating cash flow−10.7Capital expenditure−0.1Free cash flow−10.7Fiscal year 2022Operating cash flow−10.4Capital expenditure0.0Free cash flow−10.4Fiscal year 2023Operating cash flow−9.6Capital expenditure0.0Free cash flow−9.6Fiscal year 2024Operating cash flow8.6Capital expenditure−0.0Free cash flow8.6Fiscal year 2025Operating cash flow−10.0Capital expenditure−0.1Free cash flow−10.1 −217.8%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −8.4 −6.5 −10.8 −8.2 −7.3 −10.7 −10.4 −9.6 8.6 −10.0
Capital expenditure 0.0 −0.0 −0.0 0.0 −0.0 −0.1 0.0 0.0 −0.0 −0.1
Free cash flow −8.4 −6.5 −10.9 −8.2 −7.3 −10.7 −10.4 −9.6 8.6 −10.1
Growth −217.8%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash3.6Shareholders’ equity−0.3Fiscal year 2017Cash7.8Shareholders’ equity−1.9Fiscal year 2018Cash8.0Shareholders’ equity8.9Fiscal year 2019Cash3.8Total debt0.0Net cash (debt)3.8Shareholders’ equity6.6Debt to equity0.00Fiscal year 2020Cash1.2Total debt0.3Net cash (debt)0.9Shareholders’ equity9.7Debt to equity0.03Fiscal year 2021Cash7.9Shareholders’ equity14.6Fiscal year 2022Cash6.0Shareholders’ equity11.4Fiscal year 2023Cash2.5Shareholders’ equity6.1Fiscal year 2024Cash3.8Shareholders’ equity25.8Fiscal year 2025Cash8.7Shareholders’ equity16.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 3.6 7.8 8.0 3.8 1.2 7.9 6.0 2.5 3.8 8.7
Total debt n/a n/a n/a 0.0 0.3 n/a n/a n/a n/a n/a
Net cash (debt) n/a n/a n/a 3.8 0.9 n/a n/a n/a n/a n/a
Shareholders’ equity −0.3 −1.9 8.9 6.6 9.7 14.6 11.4 6.1 25.8 16.1
Debt to equity n/a n/a n/a 0.00 0.03 n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022† 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
0.7 0.4 1.7 2.7 0.0 0.0 n/a 0.0 16.0 0.0
Growth −39.1% +305.5% +62.5% −99.6% −100.0% −100.0%
8.4 10.3 8.1 5.4 3.6 5.4 3.4 4.0 7.8 10.8
5.6 4.6 4.4 4.4 4.7 5.3 8.3 4.7 5.5 5.7
n/a n/a −10.8 n/a −6.9 −14.2 −12.3 −12.6 4.5 −12.8
Growth −384.5%
−13.3 −14.6 −10.7 −7.0 −6.8 −14.0 −13.7 −12.4 5.7 −12.1
0.0 −1.3 0.1 0.1 0.0 −0.2 −0.1 0.1 2.1 −1.3
−13.3 −13.2 −10.8 −7.1 −6.9 −13.8 −13.6 −12.5 3.6 −10.8
Growth −401.4%
Per share
n/a n/a n/a n/a −1.49 −57.12 −18.55 −24.25 0.93 −2.60
n/a n/a n/a n/a −1.49 −57.12 −18.55 −24.25 0.87 −2.64
Growth −403.4%
n/a n/a n/a n/a 4.6 0.2 0.7 0.5 3.9 4.2
n/a n/a n/a n/a 4.6 0.2 0.7 0.5 4.1 4.1
Growth −94.7% +203.7% −26.5% +666.7% −0.5%

† The diluted share count jumps at 2021 and 2022 and 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 9 of 10 years on file.